Topics
Glioblastoma | Treatment | Drug delivery
Home > Publications > Topics > Glioblastoma > Treatment > Drug delivery
Bukhari SS, Ahmed N, Shamim MS.
Super
selective intra-arterial cerebral infusion (SSIACI) for newly
diagnosed and recurrent glioblastoma.
J
Pak Med Assoc. 2024 Jun 28;74(7):1380-1381. doi:
10.47391/JPMA.24-55. PMID:
39028079. Review. ˍ
Rolfe NW, Dadario NB, Canoll P, Bruce JN.
A
Review of Therapeutic Agents Given by Convection-Enhanced Delivery
for Adult Glioblastoma.
Pharmaceuticals
(Basel). 2024 Jul 23;17(8):973. doi:
10.3390/ph17080973. PMID:
39204078. Review. ˍ
Firuzpour F, Saleki K, Aram C, Rezaei N.
Nanocarriers
in glioblastoma treatment: a neuroimmunological perspective.
Rev
Neurosci. 2024 Dec 30. doi:
10.1515/revneuro-2024-0097. PMID:
39733347. Review˰ ˍ
Agnihotri TG, Dahifale A, Gomte SS, Rout B, Peddinti V, Jain A.
Nanosystems at Nexus: Navigating
Nose-to-Brain Delivery for Glioblastoma Treatment.
Mol
Pharm. 2025 Jan 2. doi:
10.1021/acs.molpharmaceut.4c00703. PMID:
39746097. Review˰ ˍ
Mokarram N, Case A, Hossainy NN, Lyon JG, MacDonald TJ,
Bellamkonda R.
Device-assisted
strategies for drug delivery across the blood-brain barrier to
treat glioblastoma.
Commun
Mater. 2025 Jan 7;6(1):5. doi:
10.1038/s43246-024-00721-y. PMID:
39790893. Review. ˍ
Zhu J, Li X, Lin Z, Qu L, Guan H. 2009-2023
Bibliometric
analysis of the clinical value of graphene quantum dots in
glioblastoma treatment.
Discov
Nano. 2025 Jun 18;20(1):96. doi:
10.1186/s11671-025-04277-9. PMID:
40531247. Bibliometric analysis. ˍ
Truusalu JP, Oselin K, Lass J, Buck KK, Sietsema W, Soeorg H,
Toome K, Kaarna K, Teesalu T, Kõrgvee LT.
LSTA1-GBM-2A:
study protocol for an exploratory phase 2a randomised controlled
trial evaluating tumour-homing peptide certepetide with
temozolomide in glioblastoma multiforme.
BMJ
Open. 2025 Nov 13;15(11):e106094. doi:
10.1136/bmjopen-2025-106094. PMID:
41248393. Interventional study protocol. ˍ